Group One Trading, L.P. Intra Cellular Therapies, Inc. Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 6,641 shares of ITCI stock, worth $606,256. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,641
Previous 7,605 12.68%
Holding current value
$606,256
Previous $526,000 13.69%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$64.76 - $79.84 $62,428 - $76,965
-964 Reduced 12.68%
6,641 $454,000
Q1 2024

May 10, 2024
SELL
$64.37 - $75.65 $380,619 - $447,318
-5,913 Reduced 43.74%
7,605 $526,000
Q4 2023

Feb 14, 2024
BUY
$46.37 - $73.65 $626,829 - $995,600
13,518 New
13,518 $968,000
Q4 2022

Feb 09, 2023
BUY
$44.07 - $54.45 $243,883 - $301,326
5,534 Added 381.66%
6,984 $369,000
Q3 2022

Nov 09, 2022
BUY
$42.7 - $59.99 $61,915 - $86,985
1,450 New
1,450 $67,000
Q1 2022

May 12, 2022
SELL
$38.74 - $62.09 $369,618 - $592,400
-9,541 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$35.2 - $53.42 $636,662 - $966,207
-18,087 Reduced 65.47%
9,541 $499,000
Q3 2021

Nov 12, 2021
BUY
$28.72 - $42.49 $454,752 - $672,786
15,834 Added 134.25%
27,628 $1.03 Million
Q2 2021

Aug 10, 2021
SELL
$29.3 - $44.5 $64,167 - $97,455
-2,190 Reduced 15.66%
11,794 $481,000
Q1 2021

May 12, 2021
BUY
$30.8 - $39.51 $430,707 - $552,507
13,984 New
13,984 $474,000
Q4 2020

Feb 10, 2021
SELL
$23.34 - $32.22 $376,520 - $519,773
-16,132 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$17.61 - $31.86 $990,051 - $1.79 Million
-56,221 Reduced 77.7%
16,132 $414,000
Q2 2020

Aug 13, 2020
BUY
$14.35 - $26.64 $1.04 Million - $1.93 Million
72,353 New
72,353 $1.86 Million
Q4 2019

Feb 10, 2020
SELL
$7.26 - $38.49 $386,551 - $2.05 Million
-53,244 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$7.47 - $14.03 $397,732 - $747,013
53,244 New
53,244 $398,000
Q1 2019

May 13, 2019
SELL
$10.9 - $14.09 $213,214 - $275,614
-19,561 Closed
0 $0
Q4 2018

Feb 06, 2019
SELL
$10.36 - $20.96 $352,032 - $712,220
-33,980 Reduced 63.47%
19,561 $223,000
Q3 2018

Nov 08, 2018
SELL
$17.77 - $22.9 $269,126 - $346,820
-15,145 Reduced 22.05%
53,541 $1.16 Million
Q2 2018

Aug 14, 2018
SELL
$17.33 - $23.4 $103,893 - $140,283
-5,995 Reduced 8.03%
68,686 $1.21 Million
Q1 2018

May 11, 2018
BUY
$15.16 - $25.49 $250,124 - $420,559
16,499 Added 28.36%
74,681 $1.57 Million
Q4 2017

Feb 09, 2018
BUY
$14.27 - $16.79 $286,769 - $337,411
20,096 Added 52.76%
58,182 $842,000
Q3 2017

Nov 15, 2017
BUY
$10.77 - $22.1 $261,883 - $537,383
24,316 Added 176.59%
38,086 $601,000
Q2 2017

Aug 14, 2017
BUY
N/A
13,770
13,770 $171,000

Others Institutions Holding ITCI

# of Institutions
402
Shares Held
89.5M
Call Options Held
301K
Put Options Held
277K
View Full List

About Intra-Cellular Therapies, Inc.

ITCI Quotes by TradingView
  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.62B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email